Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study

BACKGROUND: C-type natriuretic peptide (CNP) is a known target for promoting growth and has been implicated as a therapeutic opportunity for the prevention and treatment of cardiovascular disease (CVD). This study aimed to explore the effect of CNP on CVD risk using the Mendelian randomization (MR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Cronjé, Héléne T., Karhunen, Ville, Hovingh, G. Kees, Coppieters, Ken, Lagerstedt, Jens O., Nyberg, Michael, Gill, Dipender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134514/
https://www.ncbi.nlm.nih.gov/pubmed/37101178
http://dx.doi.org/10.1186/s12916-023-02867-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134514/
https://www.ncbi.nlm.nih.gov/pubmed/37101178
http://dx.doi.org/10.1186/s12916-023-02867-x

Ejemplares similares